{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:28:58Z","timestamp":1789810138835,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuro.2011.12.011","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T05:26:37Z","timestamp":1324445197000},"page":"127-137","source":"Crossref","is-referenced-by-count":28,"title":["Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models"],"prefix":"10.1016","volume":"33","author":[{"given":"Marion","family":"Bankstahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bloms-Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.neuro.2011.12.011_bib0005","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2011.12.011_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuro.2011.12.011_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vascn.2004.02.007","article-title":"Origins, practices and future of safety pharmacology","volume":"49","author":"Bass","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuro.2011.12.011_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0920-1211(99)00118-7","article-title":"Proconvulsant effect of aminophylline on cortical epileptic afterdischarges varies during ontogeny","volume":"39","author":"Bernaskova","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0025","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1553-2712.2002.tb01609.x","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.neuro.2011.12.011_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1734-1140(11)70394-2","article-title":"Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data","volume":"63","author":"Chroscinska-Krawczyk","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neuro.2011.12.011_bib0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1528-1157.1986.tb03529.x","article-title":"Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice","volume":"27","author":"Czuczwar","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuro.2011.12.011_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1157.1990.tb05382.x","article-title":"Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice","volume":"31","author":"Czuczwar","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuro.2011.12.011_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00124509-200209000-00002","article-title":"Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal","volume":"18","author":"Datto","year":"2002","journal-title":"J ECT"},{"key":"10.1016\/j.neuro.2011.12.011_bib0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/cc6166","article-title":"Clinical review: major consequences of illicit drug consumption","volume":"12","author":"Devlin","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.neuro.2011.12.011_bib0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-8749.2003.tb00859.x","article-title":"ADHD and epilepsy in childhood","volume":"45","author":"Dunn","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.spen.2005.12.004","article-title":"Childhood epilepsy, attention problems, and ADHD: review and practical considerations","volume":"12","author":"Dunn","year":"2005","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0173(83)90039-5","article-title":"Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems","volume":"6","author":"Frenk","year":"1983","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuro.2011.12.011_bib0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0028-3908(91)90086-Q","article-title":"Effect of psychotropic agents on a model of absence epilepsy in rats","volume":"30","author":"Frey","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2011.12.011_bib0075","first-page":"122","article-title":"Pharmakologische untersuchungen zur analgesie, abh\u00e4ngigkeits- und toleranzentwicklung von tramadol, einem stark wirksamen analgetikum","volume":"28","author":"Friderichs","year":"1978","journal-title":"Arzneim-Forsch (Drug Res)"},{"key":"10.1016\/j.neuro.2011.12.011_bib0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","article-title":"Incidence of first-time idiopathic seizures in users of tramadol","volume":"20","author":"Gasse","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuro.2011.12.011_bib0085","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.neuro.2011.12.011_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1081\/CLT-44771","article-title":"Seizures reported in association with use of dietary supplements","volume":"43","author":"Haller","year":"2005","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.neuro.2011.12.011_bib0095","first-page":"631","article-title":"The effect of neuroleptics and neuroleptic\/analgesic combinations on the sensitivity to seizures in mice","volume":"37","author":"Hashem","year":"1988","journal-title":"Anaesthesist"},{"key":"10.1016\/j.neuro.2011.12.011_bib0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.vascn.2008.06.001","article-title":"Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds","volume":"58","author":"Himmel","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuro.2011.12.011_bib0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/j.1875-9114.1998.tb03123.x","article-title":"The risk of seizures associated with tramadol","volume":"18","author":"Jick","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuro.2011.12.011_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0074-7742(08)00022-6","article-title":"Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs","volume":"83","author":"Kanner","year":"2008","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/089198879500800305","article-title":"Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study","volume":"8","author":"Kelsey","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1997.03550200037026","article-title":"Seizures reported with tramadol","volume":"278","author":"Khan","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.neuro.2011.12.011_bib0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0028-3908(73)90121-4","article-title":"Central monoamines and convulsive thresholds in mice and rats","volume":"12","author":"Kilian","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2011.12.011_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3570549","article-title":"Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice","volume":"7","author":"Kimball","year":"1957","journal-title":"Radiat Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0135","first-page":"513","article-title":"Brain dopamine and seizure susceptibility in mice","volume":"30","author":"Kleinrok","year":"1978","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.neuro.2011.12.011_bib0140","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-3565(24)37532-9","article-title":"Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models","volume":"285","author":"Krupp","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2011.12.011_bib0145","first-page":"2","article-title":"CNS safety pharmacology: international guidelines and methods","volume":"8","author":"Kumar","year":"2007","journal-title":"CRIPS"},{"key":"10.1016\/j.neuro.2011.12.011_bib0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yebeh.2010.08.006","article-title":"Involvement of the nitric oxide pathway in the anticonvulsant effect of tramadol on pentylenetetrazole-induced seizures in mice","volume":"19","author":"Lesani","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuro.2011.12.011_bib0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ajhp\/54.6.643","article-title":"Tramadol: a new centrally acting analgesic","volume":"54","author":"Lewis","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.neuro.2011.12.011_bib0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(48)80169-1","article-title":"The use of benzedrine and dexedrine sulfate in the treatment of epilepsy","volume":"32","author":"Livingston","year":"1948","journal-title":"J Pediatr"},{"key":"10.1016\/j.neuro.2011.12.011_bib0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs. A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0180","series-title":"Kindling 5","first-page":"435","article-title":"Pharmacology of glutamate receptor antagonists in the kindling model","author":"L\u00f6scher","year":"1998"},{"key":"10.1016\/j.neuro.2011.12.011_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.025","article-title":"Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans","volume":"610","author":"L\u00f6scher","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2010.06.035","article-title":"Functional, metabolic, and synaptic changes after seizures as potential targets for antiepileptic therapy","volume":"19","author":"L\u00f6scher","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuro.2011.12.011_bib0195","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/0024-3205(74)90025-3","article-title":"Opiate receptor phenomenon: proconvulsant action of morphine in the mouse","volume":"15","author":"Mannino","year":"1974","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2011.12.011_bib0200","first-page":"407","article-title":"Tramadol, a centrally acting opioid: anticonvulsant effect against maximal electroshock seizure in mice","volume":"42","author":"Manocha","year":"1998","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2005.07.013","article-title":"On the mechanism of anticonvulsant effect of tramadol in mice","volume":"82","author":"Manocha","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2011.12.011_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0163-8343(87)90025-9","article-title":"Seizures with neuroleptics and antidepressants","volume":"9","author":"Markowitz","year":"1987","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.neuro.2011.12.011_bib0215","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1345\/aph.1E577","article-title":"Tramadol exposures reported to statewide poison control system","volume":"39","author":"Marquardt","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.neuro.2011.12.011_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-4274(98)00023-X","article-title":"The experimental toxicology of tramadol: an overview","volume":"95","author":"Matthiesen","year":"1998","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.neuro.2011.12.011_bib0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuro.2011.12.011_bib0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0773.1993.tb01639.x","article-title":"Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice","volume":"72","author":"Ogren","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0235","first-page":"135","article-title":"Allgemeine pharmakologische Untersuchungen mit Tramadol, einem stark wirkenden Analgetikum","volume":"28","author":"Osterloh","year":"1978","journal-title":"Arzneim-Forsch (Drug Res)"},{"key":"10.1016\/j.neuro.2011.12.011_bib0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.neuro.2011.12.011_bib0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0160-5402(85)90057-9","article-title":"A timed intravenous pentylenetetrazol infusion seizure model for quantitating the anticonvulsant effect of valproic acid in the rat","volume":"13","author":"Pollack","year":"1985","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.neuro.2011.12.011_bib0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1472-8206.2002.00061.x","article-title":"New perspectives in CNS safety pharmacology","volume":"16","author":"Porsolt","year":"2002","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bjp.0703562","article-title":"Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy","volume":"131","author":"Potschka","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2011.12.011_bib0265","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/jpet.108.137273","article-title":"Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice","volume":"325","author":"Raffa","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2011.12.011_bib0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2011.12.011_bib0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-7843.2008.00276.x","article-title":"Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway","volume":"103","author":"Rehni","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0280","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"521","article-title":"Opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.neuro.2011.12.011_bib0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00431736","article-title":"The effects of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous catecholamine concentrations and their rates of biosynthesis in mice","volume":"51","author":"Riffee","year":"1977","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuro.2011.12.011_bib0290","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0031-3955(16)31260-3","article-title":"The diagnosis and treatment of seizures","volume":"9","author":"Scholl","year":"1962","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.neuro.2011.12.011_bib0295","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0310057X0002800403","article-title":"Tramadol\u2014present and future","volume":"28","author":"Shipton","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.neuro.2011.12.011_bib0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/dev.420160203","article-title":"Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats","volume":"16","author":"Spear","year":"1983","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/15563659709043367","article-title":"Prospective multicenter evaluation of tramadol exposure","volume":"35","author":"Spiller","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.neuro.2011.12.011_bib0310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00124509-199912000-00003","article-title":"Aminophylline increases seizure length during electroconvulsive therapy","volume":"15","author":"Stern","year":"1999","journal-title":"J ECT"},{"key":"10.1016\/j.neuro.2011.12.011_bib0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006842-194404000-00004","article-title":"The effect of mental activity on the incidence of seizures and the electroencephalographic pattern in some epileptics","volume":"6","author":"Strauss","year":"1944","journal-title":"Psychonom Med"},{"key":"10.1016\/j.neuro.2011.12.011_bib0320","series-title":"Experimental models of epilepsy\u2014a manual for the laboratory worker","first-page":"433","article-title":"Electrically induced convulsions","author":"Swinyard","year":"1972"},{"key":"10.1016\/j.neuro.2011.12.011_bib0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/YCT.0b013e3181571ad0","article-title":"Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy","volume":"24","author":"Taylor","year":"2008","journal-title":"J ECT"},{"key":"10.1016\/j.neuro.2011.12.011_bib0330","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2006.10.035","article-title":"Effects of postnatal caffeine exposure on seizure susceptibility in developing rats","volume":"1150","author":"Tchekalarova","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2011.12.011_bib0335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03161033","article-title":"Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System","volume":"3","author":"Thundiyil","year":"2007","journal-title":"J Med Toxicol"},{"issue":"Suppl. 2","key":"10.1016\/j.neuro.2011.12.011_bib0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2002.043s2008.x","article-title":"Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations","volume":"43","author":"Torta","year":"2002","journal-title":"Epilepsia"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X11002208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X11002208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T06:51:37Z","timestamp":1742107897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X11002208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0161813X11002208"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2011.12.011","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}